Adenovirus‑mediated overexpression of bone morphogenetic protein‑9 promotes methionine choline deficiency‑induced non‑alcoholic steatohepatitis in non‑obese mice.


Journal

Molecular medicine reports
ISSN: 1791-3004
Titre abrégé: Mol Med Rep
Pays: Greece
ID NLM: 101475259

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 04 12 2018
accepted: 20 05 2019
pubmed: 20 7 2019
medline: 14 1 2020
entrez: 20 7 2019
Statut: ppublish

Résumé

Liver inflammation and macrophage infiltration are critical steps in the progression of non‑alcoholic fatty liver to the development of non‑alcoholic steatohepatitis. Bone morphogenetic protein‑9 is a cytokine involved in the regulation of chemokines and lipogenesis. However, the function of bone morphogenetic protein‑9 in non‑alcoholic steatohepatitis is still unknown. The present study hypothesized that bone morphogenetic protein‑9 may contribute to steatohepatitis in mice fed a methionine choline deficiency diet (MCD). C57BL/6 mice overexpressing bone morphogenetic protein‑9 and control mice were fed the MCD diet for 4 weeks. Liver tissue and serum samples were obtained for subsequent measurements. Bone morphogenetic protein‑9 overexpression exacerbated steatohepatitis in mice on the MCD diet, as indicated by liver histopathology, increased serum alanine aminotransferase activity, aspartate transaminase activity, hepatic inflammatory gene expression and M1 macrophage recruitment. Although bone morphogenetic protein‑9 overexpression did not affect the expression of pro‑fibrogenic genes, including Collagen I (α)1 or matrix metalloproteinase (MMP) 9, it did upregulate the expression of transforming growth factor‑β and plasminogen activator inhibitor 1, and downregulated the expression of MMP2. The above results indicate that bone morphogenetic protein‑9 exerts a pro‑inflammatory role in MCD diet‑induced non‑alcoholic steatohepatitis.

Identifiants

pubmed: 31322255
doi: 10.3892/mmr.2019.10508
pmc: PMC6691271
doi:

Substances chimiques

Growth Differentiation Factor 2 0
RNA, Messenger 0
Methionine AE28F7PNPL

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2743-2753

Références

Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Nat Biotechnol. 2003 Mar;21(3):294-301
pubmed: 12598908
J Biol Chem. 2005 Jul 1;280(26):25111-8
pubmed: 15851468
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10289-10293
pubmed: 16801541
Circ Res. 2008 Apr 25;102(8):914-22
pubmed: 18309101
Protein Expr Purif. 2009 Feb;63(2):89-94
pubmed: 18950713
J Biol Chem. 2009 Jun 5;284(23):15794-804
pubmed: 19366699
J Interferon Cytokine Res. 2009 Jun;29(6):313-26
pubmed: 19441883
J Cell Sci. 2010 May 15;123(Pt 10):1684-92
pubmed: 20406889
Dig Dis. 2010;28(1):192-6
pubmed: 20460910
Nutr Metab (Lond). 2010 May 26;7:45
pubmed: 20504302
Gut. 2012 Mar;61(3):416-26
pubmed: 21813474
Hepatology. 2012 Nov;56(5):1751-9
pubmed: 22707395
Hepatology. 2013 Jan;57(1):385-98
pubmed: 22911542
Blood. 2012 Nov 15;120(20):4263-73
pubmed: 23018639
Cancer Sci. 2013 Mar;104(3):398-408
pubmed: 23281849
PLoS One. 2013 Jul 23;8(7):e69535
pubmed: 23936038
PLoS One. 2013 Dec 20;8(12):e84009
pubmed: 24376781
Biomaterials. 2014 Mar;35(10):3172-9
pubmed: 24439409
Int J Mol Sci. 2014 Mar 25;15(4):5199-220
pubmed: 24670474
Acta Biomater. 2015 Jan;11:37-47
pubmed: 25242651
PLoS One. 2015 Apr 24;10(4):e0122892
pubmed: 25909848
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Biochim Biophys Acta. 2016 Jul;1862(7):1237-46
pubmed: 27085971
J Immunol. 2016 Oct 15;197(8):3302-3314
pubmed: 27647829
Hepatology. 2017 May;65(5):1720-1734
pubmed: 28090670
J Hepatol. 2017 Jun;66(6):1300-1312
pubmed: 28267621
Gut. 2017 May;66(5):939-954
pubmed: 28336518
Clin Cancer Res. 2017 Dec 1;23(23):7388-7399
pubmed: 28928159
Matrix Biol. 2018 Aug;68-69:452-462
pubmed: 29221811
Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):709-720
pubmed: 29223735
J Clin Transl Hepatol. 2017 Dec 28;5(4):384-393
pubmed: 29226105
Br J Pharmacol. 2018 Mar;175(6):953-967
pubmed: 29281143
Transplantation. 2019 Jan;103(1):e1-e13
pubmed: 30300287
Endocrinology. 1995 Oct;136(10):4293-7
pubmed: 7664647

Auteurs

Qi Li (Q)

Department of Hepatology and Gastroenterology, Beijing You An Hospital, Capital Medical University, Beijing 100069, P.R. China.

Beibei Liu (B)

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.

Katja Breitkopf-Heinlein (K)

Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, D‑68167 Mannheim, Germany.

Honglei Weng (H)

Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, D‑68167 Mannheim, Germany.

Qianqian Jiang (Q)

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.

Peiling Dong (P)

Department of Hepatology and Gastroenterology, Beijing You An Hospital, Capital Medical University, Beijing 100069, P.R. China.

Steven Dooley (S)

Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, D‑68167 Mannheim, Germany.

Keshu Xu (K)

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.

Huiguo Ding (H)

Department of Hepatology and Gastroenterology, Beijing You An Hospital, Capital Medical University, Beijing 100069, P.R. China.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH